Transcriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective manner

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Hameed, Umar Farook Shahul ^a   Lim, Jackwee ^a   Zhang, Qian ^b   Wasik, Mariusz A ^b   Yang, Daiwen ^a   Swaminathan, Kunchithapadam ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

BINDING SITE; CELL CULTURE; CELL NUCLEUS; CPG ISLAND; DNA METHYLATION; ESCHERICHIA COLI; GENE SILENCING; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

BINDING SITES; CELL NUCLEUS; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; ESCHERICHIA COLI; GENE SILENCING; HISTONE DEACETYLASES; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84901044328     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04896     Document Type: Article

References (45)

1. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev 16, 6-21, doi:10. 1101/gad. 947102 (2002). (Pubitemid 34049633)
2. Rottach, A., Leonhardt, H. & Spada, F. DNA methylation-mediated epigenetic control. J Cell Biochem 108, 43-51, doi:10. 1002/jcb. 22253 (2009).
3. Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L. & Jaenisch, R. DNA hypomethylation leads to elevated mutation rates. Nature 395, 89-93, doi:10. 1038/nature. 25779 (1998). (Pubitemid 28420236)
4. Illingworth, R. et al. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 6, e22, doi:10. 1371/journal. pbio. 0060022 (2008).
5. Costello, J. F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24, 132-138, doi:10. 1038/nat. gen. 72785 (2000). (Pubitemid 30094712)
6. Maunakea, A. K. et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466, 253-257, doi:10. 1038/nature. 09165 (2010).
7. Sproul, D. et al. Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci U S A 108, 4364-4369, doi:10. 1073/pnas. 1013224108 (2011).
8. Christoph, F. et al. A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer. J Cancer Res Clin Oncol 133, 343-349, doi:10. 1007/s00432-006-0174-9 (2007). (Pubitemid 46716698)
9. Esteller, M., Corn, P. G., Baylin, S. B. & Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229 (2001). (Pubitemid 32695003)
10. Ballestar, E. & Wolffe, A. P. Methyl-CpG-binding proteins. Targeting specific gene repression. Eur J Biochem 268, 1-6, doi:ejb1869 (2001). (Pubitemid 32052241)
11. Clouaire, T., de Las Heras, J. I., Merusi, C. &Stancheva, I. Recruitment ofMBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res 38, 4620-4634, doi:10. 1093/nar/gkq228 (2010).
12. Zou, X., Ma, W., Solov'yov, I. A., Chipot, C. & Schulten, K. Recognition of methylated DNA through methyl-CpG binding domain proteins. Nucleic Acids Res 40, 2747-2758, doi:10. 1093/nar/gkr1057 (2012).
13. Fujita, N. et al. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol Cell Biol 19, 6415-6426 (1999). (Pubitemid 29399345)
14. Ng, H. H., Jeppesen, P. & Bird, A. Active repression of methylated genes by the chromosomal protein MBD1. Mol Cell Biol 20, 1394-1406 (2000). (Pubitemid 30069259)
15. Sakamoto, Y. et al. Overlapping roles of the methylated DNA-binding protein MBD1 and polycomb group proteins in transcriptional repression of HOXA genes and heterochromatin foci formation. J Biol Chem 282, 16391-16400, doi:10. 1074/jbc. M700011200 (2007). (Pubitemid 47100342)
16. Ohki, I., Shimotake, N., Fujita, N., Nakao, M. & Shirakawa, M. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1. EMBO J 18, 6653-6661, doi:10. 1093/emboj/18. 23. 6653 (1999).
17. Ohki, I. et al. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 105, 487-497, doi:S0092-8674(01)00324-5 (2001). (Pubitemid 32520854)
18. Cierpicki, T. et al. Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia. Nat Struct Mol Biol 17, 62-68, doi:10. 1038/nsmb. 1714 (2010).
19. Fujita, N. et al. MCAF mediates MBD1-dependent transcriptional repression. Mol Cell Biol 23, 2834-2843 (2003). (Pubitemid 36403081)
20. Ichimura, T. et al. Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins. J Biol Chem 280, 13928-13935, doi:10. 1074/jbc. M413654200 (2005). (Pubitemid 40517293)
21. Sarraf, S. A. & Stancheva, I. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell 15, 595-605, doi:10. 1016/j. molcel. 2004. 06. 043 (2004). (Pubitemid 39141786)
22. Villa, R. et al. The methyl-CpG binding protein MBD1 is required for PMLRARalpha function. Proc Natl Acad Sci U S A 103, 1400-1405, doi:10. 1073/pnas. 0509343103 (2006). (Pubitemid 43191177)
23. Watanabe, S. et al. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc Natl Acad Sci U S A 100, 12859-12864, doi:10. 1073/pnas. 2131819100 (2003). (Pubitemid 37339990)
24. Jones, P. L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19, 187-191, doi:10. 1038/561 (1998). (Pubitemid 28248804)
25. Patra, S. K., Patra, A., Zhao, H., Carroll, P. & Dahiya, R. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2. Biochem Biophys Res Commun 302, 759-766, doi:S0006291X03002535 (2003). (Pubitemid 36294038)
26. Moréra, S. et al. Biochemical and structural characterization of the glycosylase domain of MBD4 bound to thymine and 5-hydroxymethyuracil- containing DNA. Nucleic Acids Res 40, 9917-9926, doi:10. 1093/nar/gks714 (2012).
27. Manvilla, B. A., Maiti, A., Begley, M. C., Toth, E. A. & Drohat, A. C. Crystal structure of humanmethyl-binding domain IV glycosylase bound to abasic DNA. J Mol Biol 420, 164-175, doi:10. 1016/j. jmb. 2012. 04. 028 (2012).
28. Fujita, N. et al. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol Cell Biol 20, 5107-5118 (2000). (Pubitemid 30431564)
29. Andresen, C. et al. Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding. Nucleic Acids Res 40, 6353-6366, doi:10. 1093/nar/gks263 (2012).
30. Baker, J. M. et al. CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat Struct Mol Biol 14, 738-745, doi:10. 1038/nsmb1278 (2007). (Pubitemid 47220063)
31. Liu, C. et al. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 6, 433-444, doi:10. 1016/j. stem. 2010. 02. 017 (2010).
32. Nakao, M. et al. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1. Brain Dev 23 Suppl 1, S174-176, doi:S0387760401003485 (2001).
33. Lyst, M. J., Nan, X. & Stancheva, I. Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins. EMBO J 25, 5317-5328, doi:10. 1038/sj. emboj. 7601404 (2006). (Pubitemid 44764141)
34. Bell, S., Klein, C., Müller, L., Hansen, S. & Buchner, J. p53 contains large unstructured regions in its native state. J Mol Biol 322, 917-927 (2002). (Pubitemid 35266503)
35. Luo, G. et al. RNAinterference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles. Cancer Biol Ther 8, 594-598 (2009).
36. Jang, J. S. et al. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14, 2474-2480, doi:10. 1158/1055-9965. EPI-05-0423 (2005).
37. Foulks, J. M. et al. Epigenetic drug discovery: targeting DNA methyltransferases. J Biomol Screen 17, 2-17, doi:10. 1177/1087057111421212 (2012).
38. Lyko, F. & Brown, R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97, 1498-1506, doi:10. 1093/jnci/dji311 (2005). (Pubitemid 41631949)
39. Marley, J., Lu, M. & Bracken, C. A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR 20, 71-75 (2001). (Pubitemid 32519656)
40. Xu, Y., Zheng, Y., Fan, J. S. & Yang, D. A new strategy for structure determination of large proteins in solution without deuteration. Nat Methods 3, 931-937, doi:10. 1038/nmeth938 (2006). (Pubitemid 44614729)
41. Brown, A. Analysis of cooperativity by isothermal titration calorimetry. Int J Mol Sci 10, 3457-3477, doi:10. 3390/ijms10083457 (2009).
42. Wiseman, T., Williston, S., Brandts, J. F. & Lin, L. N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 179, 131-137 (1989). (Pubitemid 19149635)
43. Li, X., Wang, G., Chen, D. & Lu, Y. Binding of ascorbic acid and a-tocopherol to bovine serum albumin: a comparative study. Mol Biosyst 10, 326-337, doi:10. 1039/c3mb70373h (2014).
44. Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S. & Sykes, B. D. 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR 5, 67-81 (1995).
45. Schwarzinger, S. et al. Sequence-dependent correction of random coil NMR chemical shifts. J Am Chem Soc 123, 2970-2978, doi:ja003760i (2001). (Pubitemid 32879567)